Evotec SE (EVO) Non-Current Assets (2020 - 2026)
Evotec SE's (EVO) quarterly Non-Current Assets came in at $1.1 million in Q1 2026, down 15.36% year-on-year from $1.3 million in Q1 2025, and down 1.8% quarter-over-quarter from $1.1 million in Q4 2025.
Evotec SE (EVO) Non-Current Assets (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Non-Current Assets across 7 years of filings, most recently posting $1.1 million for Q1 2026.
- Non-Current Assets for Q1 2026 came in at $1.1 million, down 15.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (down 15.36% YoY), and the FY2025 annual result was $1.1 million, down 99.92% from the prior year.
- Non-Current Assets came in at $1.1 million for Q1 2026 at Evotec SE, down from $1.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.5 billion in Q4 2023 to a low of $1.1 million in Q1 2026.
- The 5-year median for Non-Current Assets is $1.3 million (2025), against an average of $320.1 million.
- Across the five-year window, Non-Current Assets soared 36.53% in 2023 and plunged 99.92% in 2025, its largest moves.
- Evotec SE's Non-Current Assets stood at $1.1 billion in 2022, then jumped by 36.53% to $1.5 billion in 2023, then decreased by 9.42% to $1.3 billion in 2024, then slumped by 99.92% to $1.1 million in 2025, then fell by 1.8% to $1.1 million in 2026.
- The last three Non-Current Assets figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.40 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.22 Bn |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.31 Bn |
| Sep 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 1.45 Bn |
| Dec 31, 2022 | 1.06 Bn |
| Sep 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | 970.17 Mn |
| Sep 30, 2021 | 1.34 Mn |
| Dec 31, 2020 | 898.44 Mn |